New injection could smooth neck bands in phase 3 trial
NCT ID NCT07122193
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether NT 201 (incobotulinumtoxinA, a botulinum toxin type A injection) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) compared to a placebo. About 300 adults in the US are participating in this double-blind study. The main goal is to see if the treatment improves neck band appearance by at least two grades on a five-point scale at two weeks after injection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- incobotulinumtoxinA (a botulinum toxin type A injection, also known as Xeomin)
- What this could lead to
- If it works, this could provide a safe and effective treatment to reduce the appearance of neck bands (platysma prominence) in adults.
- What could go wrong
- This is a cosmetic treatment, not a cure for any disease. Results may vary, and there are risks like allergic reactions or temporary muscle weakness. The trial is still ongoing, so final results are not yet available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACETYLCHOLINE RELEASE INHIBITORS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Merz Investigative Site
Scottsdale, Arizona, 85260, United States
-
Merz Investigative Site
Encino, California, 91436, United States
-
Merz Investigative Site
Los Angeles, California, 90069, United States
-
Merz Investigative Site
Redondo Beach, California, 90277, United States
-
Merz Investigative Site
Santa Monica, California, 90404, United States
-
Merz Investigative Site
Vista, California, 92803, United States
-
Merz Investigative Site
Greenwood Village, Colorado, 80111, United States
-
Merz Investigative Site
Westport, Connecticut, 06880, United States
-
Merz Investigative Site
Washington D.C., District of Columbia, 20037, United States
-
Merz Investigative Site
Aventura, Florida, 33180, United States
-
Merz Investigative Site
Boca Raton, Florida, 33431, United States
-
Merz Investigative Site
Bradenton, Florida, 34209, United States
-
Merz Investigative Site
Coral Gables, Florida, 33143, United States
-
Merz Investigative Site
Coral Gables, Florida, 33146, United States
-
Merz Investigative Site
West Palm Beach, Florida, 33404, United States
-
Merz Investigative Site
Alpharetta, Georgia, 30005, United States
-
Merz Investigative Site
Naperville, Illinois, 60563, United States
-
Merz Investigative Site
Hunt Valley, Maryland, 21030, United States
-
Merz Investigative Site
Mount Kisco, New York, 10549, United States
-
Merz Investigative Site
New York, New York, 10021, United States
-
Merz Investigative Site
New York, New York, 10028, United States
-
Merz Investigative Site
Chapel Hill, North Carolina, 27517, United States
-
Merz Investigative Site
Wilmington, North Carolina, 28405, United States
-
Merz Investigative Site
Ardmore, Pennsylvania, 19003, United States
-
Merz Investigative Site
Nashville, Tennessee, 37215, United States
-
Merz Investigative Site
Dallas, Texas, 75225, United States
-
Merz Investigative Site
Arlington, Virginia, 22209, United States
-
Merz Investigative Site
San Juan, 00917, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a targeted drug delay prostate cancer progression?
- Can a blend of lemon verbena and saffron curb emotional eating?
- Placenta cells tested as COVID fighter – but trial stopped early
- Could a ketamine mist lift severe depression fast?
- No more needles? new device could make dental shots painless for children
- Could aspirin and ketamine be the next depression breakthrough?